Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting - Segment Reporting Information, by Segment (Details)

v3.21.2
Segment Reporting - Segment Reporting Information, by Segment (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Segment Reporting Information [Line Items]        
Revenues $ 20,991,621 $ 15,410,553 $ 58,758,383 $ 41,644,832
Depreciation and amortization 1,662,255 714,288 4,275,140 2,061,937
Segment operating income 1,338,878 1,705,356 5,345,305 2,717,290
Other expense, net 16,139 25,667 54,050 55,248
Income before income tax (benefit) expense 1,322,739 1,679,689 5,291,255 2,662,042
Operating Segments        
Segment Reporting Information [Line Items]        
Segment operating income 5,397,910 4,718,440 16,302,864 11,441,180
Unallocated corporate        
Segment Reporting Information [Line Items]        
Segment operating income (4,059,032) (3,013,084) (10,957,559) (8,723,890)
Corporate clinics        
Segment Reporting Information [Line Items]        
Revenues 11,634,009 8,403,844 32,537,942 22,554,946
Corporate clinics | Operating Segments        
Segment Reporting Information [Line Items]        
Depreciation and amortization 1,538,251 636,734 3,879,786 1,828,643
Segment operating income 1,241,081 1,313,717 4,415,793 2,662,643
Franchise operations        
Segment Reporting Information [Line Items]        
Revenues 9,357,612 7,006,709 26,220,441 19,089,886
Franchise operations | Operating Segments        
Segment Reporting Information [Line Items]        
Depreciation and amortization 165,475 342 166,159 1,027
Segment operating income 4,156,829 3,404,723 11,887,071 8,778,537
Corporate administration        
Segment Reporting Information [Line Items]        
Depreciation and amortization $ (41,471) $ 77,212 $ 229,195 $ 232,267